SCHEMBL660232

SCHEMBL660232

NC(=O)Cc1ccc(OC[C@@H](O)CO)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.66
TDP1 Q9NUW8 2/20 0.66
CYP1A2 P05177 2/20 0.66
ADRB2 P07550 1/20 0.66
ADRB1 P08588 1/20 0.66
CNR1 P21554 1/20 0.66
ADRA1D P25100 1/20 0.66
ADRA1A P35348 1/20 0.66
ADRA1B P35368 1/20 0.66
KDM4E B2RXH2 1/20 0.66
GLA P06280 1/20 0.66
CYP3A4 P08684 1/20 0.66
TSHR P16473 1/20 0.66
NFKB1 P19838 1/20 0.66
THPO P40225 1/20 0.66
BLM P54132 1/20 0.66
PMP22 Q01453 1/20 0.66
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660231 1.00 LMNA (0.66) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL31426840 0.87 LMNA (0.66) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL14283101 0.82 LMNA (0.67) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL5672642 0.82 LMNA (0.60) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL14403716 0.82 ADRB1 (0.76) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL10949087 0.81 LMNA (0.66) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL6228324 0.80 AR (0.61) LMNACYP1A2KDM4EGLATSHR
SCHEMBL28572985 0.80 CYP1A2 (0.54) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL6201961 0.80 LMNA (0.65) LMNATDP1CYP1A2ADRB2ADRB1
SCHEMBL4688462 0.80 LMNA (0.57) LMNACYP1A2THPOPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120045505-A1 FIXED DOSE DRUG COMBINATION FORMULATIONS DR. REDDY'S LABORATORIES, INC. (US) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045505-A1 FIXED DOSE DRUG COMBINATION FORMULATIONS SLC5A6, TNNT2, SIRT6 LMNA 588/4885TDP1 2568/4885CYP1A2 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.